Medical devices, healthcare technology and the business of care
510(k) clearance · K251794

Tenax Laser Resistant Endotracheal Tube

Bryan Medical, Inc. · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONK251794

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 3, 2026 for K251794, the Tenax® Laser Resistant Endotracheal Tube from Bryan Medical, Inc., under 21 CFR 868.5730 (Tracheal Tube, Class II, product codes BTR and BSK, Anesthesiology panel). SESE is a 510(k) clearance, not a PMA approval. The submission was received June 12, 2025 per the FDA database, while the clearance letter lists a dated and received date of August 4, 2026; the discrepancy is unresolved in the source.

The cleared device is a sterile, single-use endotracheal tube with two inflatable cuffs, an inner aluminum scattering layer for laser resistance, and an internal dye warning indicator. The modification adds 4.0, 4.5 and 8.5 mm sizes to the 5.0–7.5 mm range and makes two material changes across all sizes, relative to the primary predicate K213028 and earlier clearance K200761. The summary states performance testing showed no impact to safety and effectiveness; the underlying test data and the specific material changes are not described in the available excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Anesthesiology
Decision date
Sep 3, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K251794
Regulatory pathway
510(k) premarket notification
Product code
BTR
Decision code
SESE
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Tube, Tracheal (W/Wo Connector).

Product code
BTR
FDA device class
2

FDA decision timeline

  1. K251794 received

    Application receipt date recorded by FDA.

  2. K251794 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bryan Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Cincinnati, OH

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records